GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » U2Bio Co Ltd (XKRX:221800) » Definitions » ROA %

U2Bio Co (XKRX:221800) ROA % : -3.81% (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is U2Bio Co ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. U2Bio Co's annualized Net Income for the quarter that ended in Sep. 2024 was ₩-1,798 Mil. U2Bio Co's average Total Assets over the quarter that ended in Sep. 2024 was ₩47,158 Mil. Therefore, U2Bio Co's annualized ROA % for the quarter that ended in Sep. 2024 was -3.81%.

The historical rank and industry rank for U2Bio Co's ROA % or its related term are showing as below:

XKRX:221800' s ROA % Range Over the Past 10 Years
Min: -6.58   Med: 1.29   Max: 28.71
Current: -2.38

During the past 9 years, U2Bio Co's highest ROA % was 28.71%. The lowest was -6.58%. And the median was 1.29%.

XKRX:221800's ROA % is ranked better than
53.98% of 226 companies
in the Medical Diagnostics & Research industry
Industry Median: -4.83 vs XKRX:221800: -2.38

U2Bio Co ROA % Historical Data

The historical data trend for U2Bio Co's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U2Bio Co ROA % Chart

U2Bio Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
Get a 7-Day Free Trial Premium Member Only -0.04 -6.58 28.71 28.50 1.29

U2Bio Co Quarterly Data
Jun22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROA % Get a 7-Day Free Trial -2.47 -2.58 -2.84 -0.22 -3.81

Competitive Comparison of U2Bio Co's ROA %

For the Diagnostics & Research subindustry, U2Bio Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


U2Bio Co's ROA % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, U2Bio Co's ROA % distribution charts can be found below:

* The bar in red indicates where U2Bio Co's ROA % falls into.



U2Bio Co ROA % Calculation

U2Bio Co's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=645.895/( (51028.368+49199.391)/ 2 )
=645.895/50113.8795
=1.29 %

U2Bio Co's annualized ROA % for the quarter that ended in Sep. 2024 is calculated as:

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=-1798.44/( (47068.272+47247.975)/ 2 )
=-1798.44/47158.1235
=-3.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Sep. 2024) net income data. ROA % is displayed in the 30-year financial page.


U2Bio Co  (XKRX:221800) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Sep. 2024 )
=Net Income/Total Assets
=-1798.44/47158.1235
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-1798.44 / 25737.84)*(25737.84 / 47158.1235)
=Net Margin %*Asset Turnover
=-6.99 %*0.5458
=-3.81 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) net income data. The Revenue data used here is four times the quarterly (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


U2Bio Co ROA % Related Terms

Thank you for viewing the detailed overview of U2Bio Co's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


U2Bio Co Business Description

Traded in Other Exchanges
N/A
Address
Basement 1, 68 Gumaro Songpagu, Seoul, KOR
U2Bio Co Ltd provides vitro diagnostic test services. The company is engaged in offering general diagnostic tests, molecular diagnostic tests, and breastfeeding nutritional analysis services among others.

U2Bio Co Headlines

No Headlines